Stay updated on Dupilumab for AKC: Efficacy Study Clinical Trial

Sign up to get notified when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab for AKC: Efficacy Study Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    An NIH website-transition announcement banner was removed from the top of the page. The underlying page remains a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-09T13:22:40.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T13:21:33.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The clinical trial record itself is still not displayed.
    Difference
    1%
    Check dated 2026-10-26T14:37:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:16:15.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:55:39.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, with a Home link and standard header indicating an access restriction.
    Difference
    18%
    Check dated 2026-09-21T22:25:54.000Z thumbnail image

Stay in the know with updates to Dupilumab for AKC: Efficacy Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.